Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Smartphone Application for Post-Discharge Symptom Monitoring.
- Who it may be relevant to
- Registry conditions: Acute Disease, Acute Hospitalization, Coughing, Back Pain. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Switzerland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU): a Randomized Controlled Trial.
Overview
The goal of this clinical trial is to evaluate whether the use of the medidux™ smartphone app can optimize post-discharge management for patients admitted to Acute Admission Units (AAU) with non-urgent health complaints. This trial includes adult patients (age ≥ 18) in Emergency Severity Index (ESI) triage system groups 4 (standard) or 5 (non-urgent), presenting with primary symptoms such as cough, back pain, or abdominal discomfort. The main question it aims to answer is: Can the medidux™ app reduce the incidence of AAU readmissions, emergency hospitalizations, or consultations with other medical providers within 7 days after initial admission? Researchers will compare participants using the medidux™ app (intervention arm) with those receiving standard care (control arm) to observe potential differences in the rates of readmissions, emergency hospitalizations, and medical consultations. Participants will: * use the medidux™ app to monitor their symptoms and vital parameters for 7 days after discharge (intervention arm). * receive follow-up consultations at day 7 and at day 28 to assess symptom progression and any healthcare interactions (both arms).
Interventions
- Device Smartphone Application for Post-Discharge Symptom Monitoring
This intervention involves the use of a smartphone application designed for symptom monitoring. The app enables participants to log daily health data, including symptoms and vital signs, for 7 days following discharge. It provides automated prompts and guidance for self-management, including when to seek medical assistance. The app does not provide direct medical intervention but facilitates remote symptom tracking to reduce readmissions and emergency hospitalizations. Follow-up consultations ar
Primary outcome measures
- Incidence of AAU Readmissions, Emergency Hospitalizations, and Consultations of Other Medical Providers within 7 (± 1) days [Time frame: 7 (± 1) days after the initial AAU admission]
Secondary outcome measures (12)
- Incidence of AAU Readmissions, Emergency Hospitalizations, and Consultations of Other Medical Providers within 28 (± 1) days. [Time frame: 28 (± 1) days after the initial AAU admission]
- Incidence of AAU Readmissions within 7 (± 1) days [Time frame: 7 (± 1) days after the initial AAU admission]
- Incidence of AAU Readmissions within 28 (± 1) days [Time frame: 28 (± 1) days after the initial AAU admission]
- Incidence of Emergency Hospitalizations within 7 (± 1) days [Time frame: 7 (± 1) days after the initial AAU admission]
- Incidence of Emergency Hospitalizations within 28 (± 1) days [Time frame: 28 (± 1) days after the initial AAU admission]
- Incidence of Consultations of Other Medical Providers within 7 (± 1) days [Time frame: 7 (± 1) days after the initial AAU admission]
- Incidence of Consultations of Other Medical Providers within 28 (± 1) days [Time frame: 28 (± 1) days after the initial AAU admission]
- Agreement Between ePRO-Derived AE Severity Index and Physician-Assessed AE Severity [Time frame: 7 (± 1) days after the initial AAU admission]
- Differences Between ePRO-Derived AE Severity and Physician-Assessed AE Severity Ratings [Time frame: 7 (± 1) days after the initial AAU admission]
- Number of Participant-Reported Symptoms by Severity [Time frame: Daily over the 7 (± 1) day observation period]
- Evolution of Participant-Reported Symptoms Over Time [Time frame: Daily over the 7 (± 1) day observation period]
- Participant-Assessed Usability and Usefulness of the Smartphone App [Time frame: Day 7 (± 1) after the initial AAU admission]
Eligibility criteria
Inclusion criteria
- Signed Informed Consent Form (ICF)
- Age ≥ 18 years
- (Self-)admission to the involved Acute Admissions Unit (AAU)
- "Lead symptom" identified as coughing, back pain or abdominal discomfort
- Participant within ESI triage system group 4 (standard) and 5 (non-urgent)
- German-speaking
- Ownership of a smartphone or other mobile device with iOS or Android operating system
Exclusion criteria
- Age < 18 years
- Participant whose compliance to the study's protocol, e.g. due to mental health problems, physical problems, or the private life situation, can be justifiably doubted
- Participant with insufficient knowledge about the use of a smartphone or other mobile device with iOS or Android operating system
- Participant already using or planning to use another comparable electronic patient-reported symptom monitoring system (e.g. CANKADO) during this trial
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
Switzerland · 1 center
- Notfallzentrum See-Spital Horgen — Horgen
Identifiers
NCT: NCT06655337 · AAUEffidux